RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Jeffrey Tyner(Oregon Health & Science University), Brian Druker(Oregon Health & Science University)
Cited by 69
Related Papers
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
|New England Journal of Medicine|2002|2k
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals
|Journal of Clinical Investigation|2006|260
An expanded universe of cancer targets
|Cell|2021|221